- Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile;
- Formula: C17H11N5
- Anabolic activity index: not a steroid
- Androgenic activity index: not a steroid
LETROS – PHARMACOM LABS
50 tabs x 2.5 mg
Letros, with its active agent letrozole, stands as an oral non-steroidal aromatase inhibitor, widely utilized in bodybuilding. Specifically designed for males, it aims to reduce estradiol levels by inhibiting the aromatase enzyme, responsible for converting androgens into estradiol.
Benefits:
- Potent Aromatase Inhibition: Letros is recognized as the most robust aromatase inhibitor among the three most popular choices, with a single 2.5mg tablet effectively reducing circulating estrogen levels by up to 98%.
- Gynecomastia Treatment: In certain cases, Letrozole is employed for gynecomastia treatment, particularly effective when detected in its early stages.
- Testosterone Production Enhancement: Letrozole has the capability to boost natural testosterone production by increasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH), although this is not the preferred method of treatment.
Warning and Dosage Guidelines:
- Caution Against Exceeding Dosages: Users are strongly cautioned not to exceed recommended dosages, especially in bodybuilding. A 2.5mg dose may be too high and potentially drain energy levels, making it essential to adhere to proper guidelines.
- Optimal Dosage for Bodybuilding: For aromatase inhibition in the context of bodybuilding, a 0.5-1 mg dosage every other day is advised, offering effective estrogenic protection without compromising energy levels.
In summary, Letros, with its potent aromatase inhibition properties, proves valuable in bodybuilding, with cautionary advice against exceeding recommended dosages to maintain optimal energy levels. Its role in gynecomastia treatment and potential to enhance testosterone production further highlight its versatility in the realm of hormonal regulation.
Reviews
There are no reviews yet.